Widening our Circle of Influence

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare:

For permissions and non-commercial reprint enquiries, please visit to start a request.

For author reprints, please email
Average (ratings)
No ratings
Your rating
Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

We are delighted to announce that all Arrhythmia & Electrophysiology Review articles, from our first issue back in 2012, to this issue and all future issues going forward, will soon be available in full on PubMed Central (PMC) and indexed on PubMed. Indexing of Arrhythmia & Electrophysiology Review on PubMed and PMC will increase awareness of the journal itself as well as raising the profile of authors among the wider cardiology community.

PMC is a web-based repository of biomedical and life science journal literature operated by the US National Institutes of Health (NIH). In order to be accepted onto PMC, our articles have had to undergo a rigorous scientific quality evaluation, followed by a technical evaluation. It is testament to the efforts of authors, peer reviewers and editorial board that the journal has been successful in this process, and our thanks goes out to all of you who have been involved in one way or another.

In the meantime, we will need to beware of complacency, and will be maintaining our efforts to ensure the quality of the journal throughout 2016. We would welcome your input into this process, so if you would be interested in submitting a review article or opinion piece for consideration, we look forward to hearing from you.